Elite Pharmaceuticals Inc (ELTP)
0.1232
0.00 (0.00%)
USD |
OTCM |
Apr 23, 15:59
Elite Pharmaceuticals Cash from Financing (TTM): -8.755M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -8.755M |
September 30, 2023 | -8.802M |
June 30, 2023 | -6.237M |
March 31, 2023 | 1.702M |
December 31, 2022 | 14.11M |
September 30, 2022 | 14.03M |
June 30, 2022 | 11.38M |
March 31, 2022 | -0.6671M |
December 31, 2021 | -1.859M |
September 30, 2021 | -1.855M |
June 30, 2021 | -1.834M |
March 31, 2021 | -0.8698M |
December 31, 2020 | 0.9167M |
September 30, 2020 | 0.9951M |
June 30, 2020 | 1.387M |
March 31, 2020 | 0.6895M |
December 31, 2019 | 0.5738M |
September 30, 2019 | 0.9101M |
June 30, 2019 | 1.327M |
March 31, 2019 | 1.567M |
December 31, 2018 | 2.029M |
September 30, 2018 | 1.846M |
June 30, 2018 | 1.620M |
March 31, 2018 | 1.671M |
December 31, 2017 | 2.504M |
Date | Value |
---|---|
September 30, 2017 | 4.145M |
June 30, 2017 | 6.125M |
March 31, 2017 | 8.071M |
December 31, 2016 | 9.764M |
September 30, 2016 | 8.852M |
June 30, 2016 | 8.136M |
March 31, 2016 | 8.762M |
December 31, 2015 | 9.034M |
September 30, 2015 | 11.86M |
June 30, 2015 | 14.52M |
March 31, 2015 | 12.75M |
December 31, 2014 | 16.50M |
September 30, 2014 | 14.95M |
June 30, 2014 | 12.20M |
March 31, 2014 | 11.35M |
December 31, 2013 | 4.423M |
September 30, 2013 | 2.632M |
June 30, 2013 | 1.762M |
March 31, 2013 | 1.586M |
December 31, 2012 | 0.929M |
September 30, 2012 | 0.5875M |
June 30, 2012 | 0.0739M |
March 31, 2012 | -0.1056M |
December 31, 2011 | 1.182M |
September 30, 2011 | 1.222M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-8.802M
Minimum
Sep 2023
14.11M
Maximum
Dec 2022
0.9025M
Average
0.6895M
Median
Mar 2020
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |